Free tool
Diagnostics stocks
We cover 6 companies grouped under the Diagnostics theme. The median market value in the group is $120.16M. Across the group, the median move over the past trading day is −0.72%. Price change over the past year runs from −47.7% to +162.4% across the middle 80 percent of the group, with a median of −6.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.